Strides Arcolab’s arm signs research collaboration agreement with Bio-Scaffold International

23 Oct 2013 Evaluate

Strides Arcolab’s biotech subsidiary - Stells Biopharma (previously known as Agila Biotech) has entered into Research Collaboration Agreement with Bio-Scaffold International (BSI), a Singapore based, start-up Company, to research and develop BMP and stem cell loaded 3D printed devices for various applications in Orthopaedics, Cosmetology/ Plastic and Reconstructive Surgery and Dentistry. The Research will be jointly directed by Anand Iyer, Stelis Biopharma and Margam Chandrasekaran and each Company will bear the cost of its contribution to the joint research collaboration.

BSI is a pioneer in the application of 3D printing technology for the development of novel, biocompatible scaffolds. Stelis is a cutting edge biotechnology company whose research and development efforts include the development of drug and stem cell loaded devices for the treatment of various medical conditions. Scientists from Stelis and BSI have developed a framework for initial research collaboration which would include working on multiple areas such as BMP-2/7 heterodimer loaded scaffold for orthopaedic applications and BMP2/ BMP7 loaded scaffolds for spinal fusion etc.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.  

Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×